ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,000 | -76.5% | 3,028 | -75.8% | 0.00% | – |
| Q4 2020 | $17,000 | +240.0% | 12,491 | +236.0% | 0.00% | – |
| Q3 2020 | $5,000 | -28.6% | 3,718 | -42.8% | 0.00% | – |
| Q2 2020 | $7,000 | -99.2% | 6,497 | -98.5% | 0.00% | – |
| Q4 2019 | $907,000 | -10.1% | 429,750 | -6.3% | 0.00% | – |
| Q3 2019 | $1,009,000 | +5835.3% | 458,472 | +6910.3% | 0.00% | – |
| Q2 2019 | $17,000 | -95.1% | 6,540 | -93.5% | 0.00% | – |
| Q1 2019 | $348,000 | -79.5% | 100,000 | -86.4% | 0.00% | -100.0% |
| Q4 2018 | $1,696,000 | +1156.3% | 734,600 | +1582.8% | 0.00% | – |
| Q4 2016 | $135,000 | +13400.0% | 43,653 | +26356.4% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -83.3% | 165 | -72.5% | 0.00% | – |
| Q2 2014 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 1,652,190 | $3,817,000 | 2.58% |
| LINCOLN CAPITAL CORP | 62,000 | $143,000 | 0.13% |
| Laurion Capital Management LP | 1,944,727 | $4,492,000 | 0.08% |
| Cedar Wealth Management, LLC | 46,395 | $107,000 | 0.08% |
| Fosun International Ltd | 301,708 | $709,000 | 0.04% |
| BCWM, LLC | 35,100 | $811,000 | 0.04% |
| Engineers Gate Manager LP | 170,800 | $395,000 | 0.03% |
| Alpine Global Management, LLC | 45,211 | $104,000 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $578,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 73,778 | $170,000 | 0.02% |